Join
Live feed
·
PRReleasevia Quantisnow
CalciMedica Inc. logo

CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation

ByQuantisnow·Wall Street's wire, on your screen.
CALC· CalciMedica Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CALC (CalciMedica Inc.) and more on Quantisnow.